Global orphan drug market drive by high profitability rate

  • 13 views
Uploaded on

Global Orphan Drug Market Report Highlights: …

Global Orphan Drug Market Report Highlights:

Orphan Designated Drugs in Clinical Phase: 600
Marketed Orphan Designated Drugs: 281
Highest Number of Drugs in Phase-2 Trial: 231
US Dominates Clinical Trial Process: 350 in Pipeline (Research till Registration)
Indication for Clinical Trials for Orphan Drug: More than 30% for Cancer Treatment
Share of Biological in Orphan Drug: More than 60%
Major Market: US (Sales > US$ 40 Billion)
Why Shift to Orphan Drugs
Global & Regional Orphan Drug Market Overview
Orphan Drug Designation Criteria Across US, Europe & Asia
Market Specific Reimbursement Policy for US, Europe & Asia
Regulatory Framework for US, Europe & Asia
Orphan Drug Pipeline by Phase, Orphan Designated Indication & Country

  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Be the first to comment
    Be the first to like this
No Downloads

Views

Total Views
13
On Slideshare
0
From Embeds
0
Number of Embeds
0

Actions

Shares
Downloads
0
Comments
0
Likes
0

Embeds 0

No embeds

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
    No notes for slide